425 related articles for article (PubMed ID: 21832049)
1. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
Oláh J; Vincze O; Virók D; Simon D; Bozsó Z; Tõkési N; Horváth I; Hlavanda E; Kovács J; Magyar A; Szũcs M; Orosz F; Penke B; Ovádi J
J Biol Chem; 2011 Sep; 286(39):34088-100. PubMed ID: 21832049
[TBL] [Abstract][Full Text] [Related]
2. Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins.
Szénási T; Oláh J; Szabó A; Szunyogh S; Láng A; Perczel A; Lehotzky A; Uversky VN; Ovádi J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):310-323. PubMed ID: 27671864
[TBL] [Abstract][Full Text] [Related]
3. Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25.
Tőkési N; Oláh J; Hlavanda E; Szunyogh S; Szabó A; Babos F; Magyar A; Lehotzky A; Vass E; Ovádi J
Biochim Biophys Acta; 2014 Apr; 1842(4):547-57. PubMed ID: 24463170
[TBL] [Abstract][Full Text] [Related]
4. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies.
Kovács GG; László L; Kovács J; Jensen PH; Lindersson E; Botond G; Molnár T; Perczel A; Hudecz F; Mezo G; Erdei A; Tirián L; Lehotzky A; Gelpi E; Budka H; Ovádi J
Neurobiol Dis; 2004 Nov; 17(2):155-62. PubMed ID: 15474353
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological targeting of α-synuclein and TPPP/p25 in Parkinson's disease: challenges and opportunities in a Nutshell.
Oláh J; Ovádi J
FEBS Lett; 2019 Jul; 593(13):1641-1653. PubMed ID: 31148150
[TBL] [Abstract][Full Text] [Related]
6. Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies.
Oláh J; Tokési N; Vincze O; Horváth I; Lehotzky A; Erdei A; Szájli E; Medzihradszky KF; Orosz F; Kovács GG; Ovádi J
FEBS Lett; 2006 Oct; 580(25):5807-14. PubMed ID: 17027006
[TBL] [Abstract][Full Text] [Related]
7. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases.
Kovács GG; Gelpi E; Lehotzky A; Höftberger R; Erdei A; Budka H; Ovádi J
Acta Neuropathol; 2007 Feb; 113(2):153-61. PubMed ID: 17123092
[TBL] [Abstract][Full Text] [Related]
8. Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome.
Lehotzky A; Oláh J; Szunyogh S; Szabó A; Berki T; Ovádi J
Biochim Biophys Acta; 2015 Jan; 1852(1):83-91. PubMed ID: 25445539
[TBL] [Abstract][Full Text] [Related]
9. Dual life of TPPP/p25 evolved in physiological and pathological conditions.
Oláh J; Ovádi J
Biochem Soc Trans; 2014 Dec; 42(6):1762-7. PubMed ID: 25399603
[TBL] [Abstract][Full Text] [Related]
10. Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein.
Oláh J; Lehotzky A; Szénási T; Ovádi J
Cells; 2021 Oct; 10(11):. PubMed ID: 34831132
[TBL] [Abstract][Full Text] [Related]
11. Autophagy mediates the clearance of oligodendroglial SNCA/alpha-synuclein and TPPP/p25A in multiple system atrophy models.
Mavroeidi P; Arvanitaki F; Vetsi M; Becker S; Vlachakis D; Jensen PH; Stefanis L; Xilouri M
Autophagy; 2022 Sep; 18(9):2104-2133. PubMed ID: 35000546
[TBL] [Abstract][Full Text] [Related]
12. Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential.
Oláh J; Bertrand P; Ovádi J
Expert Rev Proteomics; 2017 Apr; 14(4):301-309. PubMed ID: 28271739
[TBL] [Abstract][Full Text] [Related]
13. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6.
Tokési N; Lehotzky A; Horváth I; Szabó B; Oláh J; Lau P; Ovádi J
J Biol Chem; 2010 Jun; 285(23):17896-906. PubMed ID: 20308065
[TBL] [Abstract][Full Text] [Related]
14. Targeting the interface of the pathological complex of α-synuclein and TPPP/p25.
Szunyogh S; Oláh J; Szénási T; Szabó A; Ovádi J
Biochim Biophys Acta; 2015 Dec; 1852(12):2653-61. PubMed ID: 26407520
[TBL] [Abstract][Full Text] [Related]
15. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis.
Höftberger R; Fink S; Aboul-Enein F; Botond G; Olah J; Berki T; Ovadi J; Lassmann H; Budka H; Kovacs GG
Glia; 2010 Nov; 58(15):1847-57. PubMed ID: 20737479
[TBL] [Abstract][Full Text] [Related]
16. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
[TBL] [Abstract][Full Text] [Related]
17. Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.
Hasegawa T; Baba T; Kobayashi M; Konno M; Sugeno N; Kikuchi A; Itoyama Y; Takeda A
Neurochem Int; 2010 Dec; 57(8):857-66. PubMed ID: 20849899
[TBL] [Abstract][Full Text] [Related]
18. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
Goedert M
Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
[TBL] [Abstract][Full Text] [Related]
19. Microtubule assembly-derived by dimerization of TPPP/p25. Evaluation of thermodynamic parameters for multiple equilibrium system from ITC data.
Oláh J; Zotter Á; Hlavanda E; Szunyogh S; Orosz F; Szigeti K; Fidy J; Ovádi J
Biochim Biophys Acta; 2012 Jul; 1820(7):785-94. PubMed ID: 22484033
[TBL] [Abstract][Full Text] [Related]
20. Localization of the zinc binding tubulin polymerization promoting protein in the mice and human eye.
Tripon RG; Oláh J; Nasir T; Csincsik L; Li CL; Szunyogh S; Gong H; Flinn JM; Ovádi J; Lengyel I
J Trace Elem Med Biol; 2018 Sep; 49():222-230. PubMed ID: 29317136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
